Ceylon Cinnamon for blood sugar, lipids, BMI, and pain in painful diabetic neuropathy
Official title: The Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy: A Double-Blind Randomized Controlled Trial
Run by Jerash Private University · NCT07743073 · Data updated 2026-11-12
This trial tests whether taking Ceylon cinnamon twice daily for six months helps adults with painful diabetic peripheral neuropathy improve their blood sugar, cholesterol, BMI, and pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 164 (estimated) |
| Sponsor | Jerash Private University Academic / other |
| Locations | 1 site (Amman) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | May 30, 2026 |
| Study ends | July 30, 2026 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT07743073 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with diagnosed painful diabetic peripheral neuropathy and documented type 2 diabetes.
✕Probably not a fit
Individuals without diabetes or without PDPN, or those with chronic conditions or medications that confound outcomes, may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, double-blind, randomized controlled trial conducted at endocrinology clinics in Jordan. Adults with painful diabetic peripheral neuropathy and type 2 diabetes are randomized to receive either 500 mg of Ceylon cinnamon twice daily plus standard care or a matching placebo for six months. The study aims to see if cinnamon can favorably modify metabolic markers and pain intensity compared with standard care alone. Outcomes include blood glucose, lipid profile, body mass index, and pain scores, with attention to safety and tolerability. The trial addresses the potential role of a plant-based nutraceutical as an adjunct to conventional management of PDPN.
Why it matters
Potential benefit: If successful, participants may experience better blood sugar control, improved lipid levels, weight trends, and reduced neuropathic pain.
How similar studies have gone: Previous research on cinnamon suggests potential metabolic and anti-inflammatory effects, but robust evidence for PDPN-specific benefits remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18years diagnosed with PDPN * With documented T2DM Exclusion Criteria: * If they had coexisting chronic conditions, including chronic kidney disease (CKD), hypertension, cardiovascular disease (CVD), or cognitive/sensory impairments (e.g., reading or hearing difficulties). * individuals receiving medications that could confound blood glucose control or pain perception (such as systemic glucocorticoids, weight-loss agents, or iron and vitamin B12 supplements)
Where it's running
-
Ministry of Health Primary Healthcare Centers
Amman, Jordan Recruiting
Study contacts
- Study coordinator: Dr. Jawad AHMAD ABU-SHENNAR, Asst.Prof.Dr
- Email: JAWAD_0799@YAHOO.COM
- Phone: +962779084560
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peripheral nerve decompression plus nerve stimulation for painful diabetic neuropathy
This study looks at whether combining nerve decompression with nerve stimulation can help reduce pain in people with painful diabetic neuropathy.
-
Comparing high-frequency spinal cord stimulation to traditional methods for diabetic nerve pain
This study tests if high-frequency spinal cord stimulation can help people with painful diabetic nerve pain more effectively than traditional methods.
-
High-frequency spinal cord stimulation for leg pain from diabetic neuropathy and peripheral artery disease
This study will test whether high-frequency spinal cord stimulation can reduce walking-related leg pain in people with painful diabetic neuropathy and peripheral arterial disease who responded to a temporary SCS trial.
-
Using a smartphone app to track pain and mood changes
This study is testing a smartphone app to track pain and mood changes in people with chronic pain and healthy individuals to see how these factors affect pain over time.
-
Peripheral nerve block for painful diabetic neuropathy
This study is testing if a nerve block can help adults with painful diabetic neuropathy feel less pain without stopping their regular medications.
-
Using Low-Dose Naltrexone to Treat Painful Diabetic Neuropathy
This study is testing if low-dose naltrexone can help people with painful diabetic neuropathy feel less pain after other treatments haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.